Cargando…
WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
Autores principales: | Then, R.F., Shahnaz Shah, F.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025675/ http://dx.doi.org/10.1016/j.ekir.2023.02.1024 |
Ejemplares similares
-
WCN23-0022 SUCCESSFUL KIDNEY TRANSPLANTATION FROM COVID-19 POSITIVE DONORS
por: GAMA, R., et al.
Publicado: (2023) -
WCN23-0144 OUTCOME OF COVID 19 PATIENTS REQUIRING HEMODIALYSIS
por: SAMAD, M., et al.
Publicado: (2023) -
WCN23-0983 IMPACT OF COVID-19 PANDEMIC ON MANAGEMENT OF PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
por: Saeed, B.
Publicado: (2023) -
WCN23-0592 KIDNEY TRANSPLANTATION DURING THE THREE YEARS (2020-2022) OF COVID-19 PANDEMIC: SINGLE-CENTER EXPERIENCE
por: Komissarov, K., et al.
Publicado: (2023) -
WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
por: Bajpai, D., et al.
Publicado: (2023)